NEW HAVEN, Conn. (WTNH) — A major company announced Tuesday that it will move its headquarters out of Connecticut, but will still maintain a smaller presence in the state.
Alexion Pharmaceuticals plans to move its corporate headquarters from New Haven to Boston. The drug maker said that they will establish a research and development center in New Haven, which will keep around 450 jobs in Connecticut.
Related Content: More top executives leaving Alexion Pharmaceuticals
Alexion plans to move 400 jobs to Boston when they move in mid-2018. It’s part of a plan to reduce their global workforce by 20 percent by 2019. The company moved into their current location in New Haven in 2016.
Related Content: Pharmaceutical company to lay off more than 200 employees
Alexion has been facing challenges in 2017, with top executives leaving, staff layoffs, and other restructuring moves.
Congresswoman Rosa DeLauro (D-3) released a statement Tuesday morning in response to Alexion’s announcement.
Alexion’s decision to move their headquarters out of New Haven is shocking and shameful. New Haven is home to some of the most talented and brightest minds in the world, and Alexion will be worse off for leaving, both financially and intellectually. I understand that Alexion will be forced to pay back $27 million, plus a 5% penalty, to Connecticut taxpayers as a result of moving their headquarters. My office will be fully engaged with any constituents who are impacted by this short-sighted decision.”
The Connecticut Department of Economic and Community Development called the move very disappointing.
Alexion’s decision to move its headquarters out of the state is very disappointing, especially in light of how supportive the state has been to the company over the years as it has grown into what it is today. While Alexion will maintain a significant number of employees in state, we are requiring that all of the $20 million loan and $6 million grant be repaid—with interest and penalties—to the department in accordance to the terms of our agreement. Setbacks like this, though unfortunate, do not deter the department from pursuing smart policies and ventures with growing companies in our state.”